Literature DB >> 19108957

Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions.

Carrie B Oser1, Hannah K Knudsen, Michele Staton-Tindall, Faye Taxman, Carl Leukefeld.   

Abstract

In recent years, there has been an increased examination of organizational-level innovation adoption in substance abuse treatment organizations. However, the majority of these studies have focused on community-based treatment centers. One understudied area of the substance abuse treatment system is correctional institutions. This study uses the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) cooperative's National Criminal Justice Treatment Practices (NCJTP) survey to examine the adoption of detoxification services and pharmacotherapies for the treatment of substance abuse across a nationally representative sample of correctional institutions (n=198). There were significant differences between jails and prisons in the percentage of organizations offering detoxification services and medications. Specifically, detoxification services were offered by 5% of prisons and 34% of jails; and, medications were offered by 6% of prisons and 32% of jails. Binary logistic regression models were used to examine the associations between these services and organizational characteristics, including context, resources, previously introduced practices, culture, and systems integration. Variables measuring organizational context and previously introduced practices were significant correlates of the provision of both detoxification services and medications. Multivariate results indicated that the differences between jails and prisons remained significant after controlling for other organizational factors. Although the adoption of detoxification services and pharmacotherapies may be a controversial topic for correctional institutions, these services have the potential to improve offender well-being and reduce public health risks associated with substance abuse.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19108957      PMCID: PMC2784603          DOI: 10.1016/j.drugalcdep.2008.11.005

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  38 in total

Review 1.  Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health.

Authors:  N Freudenberg
Journal:  J Urban Health       Date:  2001-06       Impact factor: 3.671

2.  CJDATS Co-Occurring Disorders Screening Instrument for Mental Disorders (CODSI-MD): A Pilot Study.

Authors:  Stanley Sacks; Gerald Melnick; Carrie Coen; Steven Banks; Peter D Friedmann; Christine Grella; Kevin Knight
Journal:  Prison J       Date:  2007-03

3.  Public policy statement on access to appropriate detoxification services for persons incarcerated in prisons and jails.

Authors: 
Journal:  J Addict Dis       Date:  2003

Review 4.  Pharmacotherapy treatment in substance-dependent correctional populations: a review.

Authors:  Karen L Cropsey; Gabriela C Villalobos; Christina L St Clair
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

5.  Attitudes and practices regarding the use of methadone in US state and federal prisons.

Authors:  Josiah D Rich; Amy E Boutwell; David C Shield; R Garrett Key; Michelle McKenzie; Jennifer G Clarke; Peter D Friedmann
Journal:  J Urban Health       Date:  2005-05-25       Impact factor: 3.671

6.  Factors predicting unmet health services needs among incarcerated substance users.

Authors:  Egle Narevic; Thomas F Garrity; Nancy E Schoenberg; Matthew L Hiller; J Matthew Webster; Carl G Leukefeld; Michele Staton Tindall
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

7.  The National Criminal Justice Treatment Practices survey: multilevel survey methods and procedures.

Authors:  Faye S Taxman; Douglas W Young; Brian Wiersema; Anne Rhodes; Suzanne Mitchell
Journal:  J Subst Abuse Treat       Date:  2007-03-09

8.  Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison.

Authors:  John Strang; Michael Gossop; Joan Heuston; John Green; Christopher Whiteley; Anthony Maden
Journal:  Addiction       Date:  2006-08       Impact factor: 6.526

9.  Filling service gaps: Providing intensive treatment services for offenders.

Authors:  Douglas W Young; Jill L Farrell; Craig E Henderson; Faye S Taxman
Journal:  Drug Alcohol Depend       Date:  2009-03-03       Impact factor: 4.492

10.  Physicians' opinions about medications to treat alcoholism.

Authors:  Tami L Mark; Henry R Kranzler; Xue Song; Peace Bransberger; Virginia H Poole; Scott Crosse
Journal:  Addiction       Date:  2003-05       Impact factor: 6.526

View more
  15 in total

1.  Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial.

Authors:  Sandra A Springer; Angela Di Paola; Russell Barbour; Marwan M Azar; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

2.  Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.

Authors:  Peter D Friedmann; Randall Hoskinson; Michael Gordon; Robert Schwartz; Timothy Kinlock; Kevin Knight; Patrick M Flynn; Wayne N Welsh; Lynda A R Stein; Stanley Sacks; Daniel J O'Connell; Hannah K Knudsen; Michael S Shafer; Elizabeth Hall; Linda K Frisman
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

3.  Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.

Authors:  Maxim Polonsky; Lyuba Azbel; Jeffrey A Wickersham; Faye S Taxman; Evgeny Grishaev; Sergey Dvoryak; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2014-12-22       Impact factor: 4.492

4.  Barriers to substance abuse treatment in rural and urban communities: counselor perspectives.

Authors:  Erin Pullen; Carrie Oser
Journal:  Subst Use Misuse       Date:  2014-03-10       Impact factor: 2.164

5.  Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.

Authors:  Maxim Polonsky; Julia Rozanova; Lyuba Azbel; Chethan Bachireddy; Jacob Izenberg; Tetiana Kiriazova; Sergii Dvoryak; Frederick L Altice
Journal:  AIDS Behav       Date:  2016-12

6.  Rural drug users: factors associated with substance abuse treatment utilization.

Authors:  Carrie B Oser; Carl G Leukefeld; Michele Staton Tindall; Thomas F Garrity; Robert G Carlson; Russel Falck; Jichuan Wang; Brenda M Booth
Journal:  Int J Offender Ther Comp Criminol       Date:  2010-05-12

7.  The adoption of wraparound services among substance abuse treatment organizations serving criminal offenders: The role of a women-specific program.

Authors:  Carrie Oser; Hannah Knudsen; Michele Staton-Tindall; Carl Leukefeld
Journal:  Drug Alcohol Depend       Date:  2009-01-31       Impact factor: 4.492

8.  Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail.

Authors:  Ehsan Chitsaz; Jaimie P Meyer; Archana Krishnan; Sandra A Springer; Ruthanne Marcus; Nick Zaller; Alison O Jordan; Thomas Lincoln; Timothy P Flanigan; Jeff Porterfield; Frederick L Altice
Journal:  AIDS Behav       Date:  2013-10

9.  Availability and capacity of substance abuse programs in correctional settings: A classification and regression tree analysis.

Authors:  Faye S Taxman; Panagiota Kitsantas
Journal:  Drug Alcohol Depend       Date:  2009-04-22       Impact factor: 4.492

Review 10.  Mental health of prisoners: prevalence, adverse outcomes, and interventions.

Authors:  Seena Fazel; Adrian J Hayes; Katrina Bartellas; Massimo Clerici; Robert Trestman
Journal:  Lancet Psychiatry       Date:  2016-07-14       Impact factor: 27.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.